http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017050806-A9

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3600b68e5707e6383dee11181a476ac
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55561
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1132
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-117
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-117
filingDate 2016-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff2941f356004f7ed791e5786efbf8d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3ca651281f8c8d0546f925a220fd400
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdb39e818e55dfed0a3577d009958ecc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_315ab911762d36869a2b75f8a254d412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2f33e823149836a00413e973d61a7c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d90b41cf9e239bfc04ec78f3c2546b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86036b5e85fb73305cf6b8587ebe3cde
publicationDate 2018-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2017050806-A9
titleOfInvention Means for the treatment of hiv
abstract The invention relates to a non-coding sequence of deoxyribonucleic acids comprising at least one sequence motif N 1 N 2 CGN 3 N 4 , wherein N is a nucleotide comprising A, C, T, or G, and C is deoxycytidine, G is deoxyguanosine, A is deoxyadenosine and T is deoxythymidine for the treatment of viral infections. In particular, the non-coding sequence of deoxyribonucleic acids is used in combination with antiretroviral therapy and/or histone de-acet-ylase inhibitors.
priorityDate 2015-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410064
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135403804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226538705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411984
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412178
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412179
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3000346
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7765
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3220
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13711

Total number of triples: 47.